In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
386 News Items found
American Association for Cancer Research
AACR Virtual Meeting: COVID-19 and Cancer: Physician-in-Chief Lisa DeAngelis Featured on Forum About Getting Patients Back to the Clinic

Physician-in-Chief Lisa M. DeAngelis joins healthcare experts during the AACR Virtual Meeting: COVID-19 and Cancer to discuss how to safely bring patients to the clinic so they can receive vital cancer screenings and care.
Close up of microscope viewer.
Article
MSK Research Highlights, October 15, 2024

New MSK research identifies a gene mutation associated with resistance to breast cancer treatment; reports encouraging results for expanding use of a new prostate cancer radiotherapy; determines the best radiation level for avoiding complications treating spinal tumors; and finds that proton therapy is effective against previously treated head and neck cancers.
Nathanael Gray, Joshua Mendell, and Christopher Vakoc
Announcement
Three Scientists Are Named Winners of the Paul Marks Prize for Cancer Research

Memorial Sloan Kettering has named three winners of this year’s Paul Marks Prize for Cancer Research, an award that recognizes promising investigators.
Memorial Sloan Kettering Among the Top “Best Hospitals” for Cancer Care and Ranked First in Gynecology by U.S News & World Report

Memorial Sloan Kettering Cancer Center (MSK) has been ranked as the number two hospital for cancer care in the nation, according to <i>U.S. News & World Report</i> in its annual listing of Best Hospitals. Since the inception of the rankings 30 years ago, MSK has held either the first or second spot each year for cancer care. MSK was also ranked first in gynecology.
Paul Marks Prize 2021 winners
Twenty Years Of Honoring A Legacy: Three Investigators Named Winners of Memorial Sloan Kettering Cancer Center’s 2021 Paul Marks Prize for Cancer Research

Memorial Sloan Kettering Cancer Center (MSK) is proud to announce three innovative investigators as the recipients of this year’s Paul Marks Prize for Cancer Research.
Dana Pe'er and Scott Lowe
Expansion of Cell-to-Cell Communication Drives the Early Development of Pancreatic Cancer, New Research in Mice Finds

New MSK research combined sophisticated genetically engineered mouse models and advanced computational methods to map the earliest cell states leading to pancreatic ductal adenocarcinoma (PDAC), the most common type of pancreatic cancer.
Lucy Kalanithi gestures while speaking. Physicians in white lab coats look on.
Support
When Breath Becomes Air: Dr. Lucy Kalanithi Reflects on How Cancer Changed Her Family’s Life

Read a Q & A with Lucy Kalanithi, the widow of Paul Kalanithi, who wrote When Breath Becomes Air.
Rob with his wife and daughter
FDA Approves Zanidatamab for Biliary Tract Cancers With High HER2 Levels 

Learn more about a new treatment for biliary tract cancers with high levels of HER2. The drug zanidatamab has been approved by the FDA, thanks to a clinical trial co-led by MSK.
Dana Pe'er
“Beautiful Patterns in Biology”: How SKI’s Dana Pe’er Earned a Top Honor and Advocates for Women Scientists

Read an interview with Sloan Kettering Institute Computational and Systems Biology Chair Dana Pe'er.
Pictured: Johanna Joyce
In the Lab
Researchers Find Clues to How Breast Cancer Can Infiltrate the Brain

A new study sheds light on what enables breast cancer cells to spread to the brain and presents a potential target for drugs.